14222-60-7 | Protionamide

Packsize	Purity	Availability	Price	Discounted Price
100mg	98%	in stock	$6.00	$4.00
1g	98%	in stock	$10.00	$7.00
5g	96%	in stock	$32.00	$22.00
25g	98%	in stock	$71.00	$50.00
100g	98%	in stock	$198.00	$138.00
500g	98%	in stock	$573.00	$402.00

Description

• Catalog Number: AA69779
• Chemical Name: Protionamide
• CAS Number: 14222-60-7
• Molecular Formula: C9H12N2S
• Molecular Weight: 180.2700
• MDL Number: MFCD00464119
• SMILES: CCCc1cc(ccn1)C(=S)N
• NSC Number: 758962

Computed Properties

• Complexity: 159
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 12
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 3
• XLogP3: 1.5

Literature

• Activity of linezolid-containing regimens against multidrug-resistant tuberculosis in mice.

  International journal of antimicrobial agents 20140201

• Troublesome Tuberculosis: A Case Report on Multi-focal Tuberculous Osteomyelitis in An Immunocompetent Patient.

  Journal of clinical medicine research 20120201

• Pharmacotherapy for multidrug resistant tuberculosis.

  Journal of pharmacology & pharmacotherapeutics 20120101

• International spread of MDR TB from Tugela Ferry, South Africa.

  Emerging infectious diseases 20111101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• [A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis].

  Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20100901

• Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.

  Microbial drug resistance (Larchmont, N.Y.) 20100301

• Disseminated multiorgan MDR-TB resistant to virtually all first-line drugs.

  European respiratory review : an official journal of the European Respiratory Society 20091201

• Pharmacokinetics of prothionamide in patients with multidrug-resistant tuberculosis.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20090901

• [Optimization of chemotherapy regimens in children with primary pulmonary tuberculosis].

  Problemy tuberkuleza i boleznei legkikh 20090101

• [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].

  Zhonghua yi xue za zhi 20081230

• Can leprosy be eradicated with chemotherapy? An evaluation of the Malta Leprosy Eradication Project.

  Leprosy review 20081201

• Extensively drug resistant tuberculosis in a high income country: a report of four unrelated cases.

  BMC infectious diseases 20080101

• [Tuberculosis or sarcoidosis].

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20080101

• Mechanism of thioamide drug action against tuberculosis and leprosy.

  The Journal of experimental medicine 20070122

• Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up.

  BMC ear, nose, and throat disorders 20070101

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy.

  The American journal of tropical medicine and hygiene 20060301

• Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20040301

• New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method.

  The Journal of antimicrobial chemotherapy 20040101

• A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infection.

  HIV clinical trials 20040101

• Longitudinal study of tuberculosis outcomes among immunologically naive Aché natives of Paraguay.

  American journal of physical anthropology 20030601

• [Effect of glutoxim in the combination with antitubercular agents of the second choice on the growth of drug resistant Mycobacteria tuberculosis in the cultured murine lung tissue].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101

• Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR.

  Antimicrobial agents and chemotherapy 20011101

• [Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20011001

• The Malta Project--a country freed itself of leprosy. A 27-year progress study (1972-1999) of the first successful eradication of leprosy.

  Chemotherapy 20010101

• [Use of the antioxidant ionol to prevent damage to the heart from prolonged administration of antitubercular preparations].

  Biulleten' eksperimental'noi biologii i meditsiny 19831001